ArdorComm Media Group

Tuesday, July 28, 2026 11:26 AM

dementia

Blood Biomarker May Predict Women’s Dementia Risk 25 Years Before Symptoms: Study

A new study suggests that a simple blood test could help predict a woman’s risk of developing dementia up to 25 years before symptoms appear. Researchers identified a blood-based biomarker called phosphorylated tau 217 (p-tau217), a protein associated with the brain changes linked to Alzheimer’s disease. The study found that higher levels of p-tau217 were strongly linked with the later development of mild cognitive impairment and dementia among women who showed no signs of cognitive decline at the beginning of the research. “Our study suggests we may be able to identify women at elevated risk for dementia decades before symptoms emerge,” said lead author Aladdin H. Shadyab, associate professor of public health and medicine at University of California San Diego. According to Shadyab, such early detection could allow doctors to focus on prevention strategies and closer monitoring long before memory issues begin affecting daily life. The findings were published in JAMA Network Open and are based on data from the Women’s Health Initiative Memory Study, a large U.S. national study involving 2,766 women aged between 65 and 79 who were enrolled in the late 1990s and followed for up to 25 years. During the follow-up period, researchers tracked participants who developed memory or thinking problems, including dementia. Women with higher p-tau217 levels in their blood at the start of the study were found to have a significantly greater likelihood of developing dementia later in life. The risk increased as biomarker levels rose. The study also found that elevated p-tau217 levels were more strongly linked to poorer cognitive outcomes among women aged 70 and older, as well as among those carrying the APOE e4 genetic risk factor associated with Alzheimer’s disease. Additionally, the biomarker appeared to be more predictive among women who had been randomly assigned estrogen-plus-progestin hormone therapy compared to those given a placebo. Researchers noted that factors such as age, race, the APOE e4 gene, and hormone therapy use should be considered when examining the link between p-tau217 and cognitive decline. Senior author Linda K. McEvoy of the Kaiser Permanente Washington Health Research Institute said blood-based biomarkers like p-tau217 are particularly promising because they are far less invasive than traditional diagnostic methods such as brain imaging or spinal fluid tests. “This could significantly advance research into the causes of dementia and help scientists evaluate strategies that may reduce the risk of developing the condition,” McEvoy said. Source: PTI Photo Credit: Bogdanhoda

Blood Biomarker May Predict Women’s Dementia Risk 25 Years Before Symptoms: Study Read More »

Weakened Body Clock Tied to Greater Dementia Risk, Study Finds

A new study indicates that disruptions in the body’s internal clock, or circadian rhythm, may significantly raise the risk of developing dementia. Researchers found that older adults with weaker and more irregular circadian patterns were more likely to be diagnosed with the condition over time. The study suggests that when daily activity rhythms peak later in the day—particularly after mid-afternoon rather than earlier hours—the risk of dementia increases sharply. Individuals whose activity levels peaked later were found to have about a 45 per cent higher likelihood of developing dementia compared to those with earlier peaks. According to Wendy Wang, the study’s lead author from the University of Texas Southwestern Medical Center, disrupted circadian rhythms may affect key biological processes. “Such disruptions can influence inflammation and sleep, potentially leading to increased buildup of amyloid plaques in the brain or reducing the brain’s ability to clear them,” she explained. Amyloid plaques are clusters of protein fragments commonly associated with Alzheimer’s disease and are known to damage brain cells, contributing to cognitive decline and dementia. The researchers examined data from more than 2,100 adults with an average age of 79, none of whom had dementia at the beginning of the study. Participants wore chest-mounted devices that tracked their rest and activity patterns for nearly two weeks on average. They were then monitored over a three-year period. During the follow-up, 176 participants were diagnosed with dementia. The findings, published in the journal Neurology, revealed that those with weaker circadian rhythms—marked by irregular sleep and activity cycles—had nearly two-and-a-half times the dementia risk compared to individuals with strong, stable rhythms. A well-regulated circadian rhythm typically aligns closely with the 24-hour day, helping maintain consistent sleep and activity schedules regardless of seasonal or routine changes. In contrast, weaker rhythms are more susceptible to disruptions from light exposure or schedule shifts, often resulting in fluctuating sleep patterns. The study also highlighted timing differences in daily activity. Participants whose peak activity occurred after 2:15 pm faced a significantly higher dementia risk compared to those whose activity peaked earlier in the afternoon. Researchers noted that a delayed activity peak may reflect a mismatch between the body’s internal clock and external environmental cues such as daylight and darkness. Wang added that while changes in circadian rhythms are a natural part of ageing, growing evidence suggests these disruptions may play a role in neurodegenerative diseases. “Our findings show that fragmented rhythms and delayed activity patterns are associated with a higher risk of dementia,” she said. The research underscores the potential importance of maintaining regular sleep-wake cycles and daily routines as people age, though further studies are needed to determine whether improving circadian health can help reduce dementia risk. Source: PTI

Weakened Body Clock Tied to Greater Dementia Risk, Study Finds Read More »